Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_4
1
20%
Ph phase_3
2
40%
Ph not_applicable
1
20%
Ph phase_1
1
20%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (20.0%)
Phase 32 (40.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

completed480%
not_yet_recruiting120%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingphase_3

Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer

NCT06787118
completedphase_1

Safety of Co-Administered CHI-554 and Alcohol

NCT05317507
completedphase_3

Effectiveness of Cannabinoids on Appetite in Scleroderma

NCT05416697
completedphase_4

Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV

NCT05209867
completednot_applicable

Comparison of Cannabinoids to Placebo in Management of TMJ Pain and Myofascial Pain in the TMJ Region

NCT04298554

Clinical Trials (5)

Showing 5 of 5 trials
NCT06787118Phase 3

Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer

Not Yet Recruiting
NCT05317507Phase 1

Safety of Co-Administered CHI-554 and Alcohol

Completed
NCT05416697Phase 3

Effectiveness of Cannabinoids on Appetite in Scleroderma

Completed
NCT05209867Phase 4

Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV

Completed
NCT04298554Not Applicable

Comparison of Cannabinoids to Placebo in Management of TMJ Pain and Myofascial Pain in the TMJ Region

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5